Literature DB >> 28658553

Type two innate lymphoid cells: the Janus cells in health and disease.

Hadi Maazi1, Omid Akbari.   

Abstract

Innate lymphoid cells are functionally diverse subsets of immune cells including the conventional natural killer cells, lymphoid tissue inducers, type 1, 2, and 3 with significant roles in immunity and pathogenesis of inflammatory diseases. Type 2 innate lymphoid cells (ILC2s) resemble type 2 helper (Th2) cells in cytokine production and contribute to anti-helminth immunity, maintaining mucosal tissue integrity, and adipose tissue browning. ILC2s play important roles in the pathogenesis of allergic diseases and asthma. Studying the pathways of activation and regulation of ILC2s are currently a priority for giving a better understanding of pathogenesis of diseases with immunological roots. Recently, our laboratory and others have shown several pathways of regulation of ILC2s by co-stimulatory molecules such as ICOS, regulatory T cells and by compounds such as nicotine. In this review, we summarize the current understanding of the mechanisms of activation and regulation of ILC2s and the role of these cells in health and disease.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Th1/Th2/Th17 cells; asthma; eosinophils; fungal; parasitic-helminth

Mesh:

Substances:

Year:  2017        PMID: 28658553      PMCID: PMC5492968          DOI: 10.1111/imr.12554

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  183 in total

1.  Fungal chitin from asthma-associated home environments induces eosinophilic lung infiltration.

Authors:  Steven J Van Dyken; Daniel Garcia; Paul Porter; Xiaozhu Huang; Patricia J Quinlan; Paul D Blanc; David B Corry; Richard M Locksley
Journal:  J Immunol       Date:  2011-08-08       Impact factor: 5.422

2.  Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain.

Authors:  Mélanie Pichery; Emilie Mirey; Pascale Mercier; Emma Lefrancais; Arnaud Dujardin; Nathalie Ortega; Jean-Philippe Girard
Journal:  J Immunol       Date:  2012-02-27       Impact factor: 5.422

3.  Innate lymphoid cells: a paradigm for low SSI in cleft lip repair.

Authors:  Erika Simmerman; Xu Qin; Brendan Marshall; Libby Perry; Lei Cai; Tailing Wang; Jack Yu; Omid Akbari; Babak Baban
Journal:  J Surg Res       Date:  2016-07-05       Impact factor: 2.192

4.  Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells.

Authors:  Anja Fuchs; William Vermi; Jacob S Lee; Silvia Lonardi; Susan Gilfillan; Rodney D Newberry; Marina Cella; Marco Colonna
Journal:  Immunity       Date:  2013-02-28       Impact factor: 31.745

5.  ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice.

Authors:  Daniela Paclik; Christina Stehle; Annette Lahmann; Andreas Hutloff; Chiara Romagnani
Journal:  Eur J Immunol       Date:  2015-08-31       Impact factor: 5.532

6.  Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity.

Authors:  Hye Young Kim; Ya-Jen Chang; Srividya Subramanian; Hyun-Hee Lee; Lee A Albacker; Ponpan Matangkasombut; Paul B Savage; Andrew N J McKenzie; Dirk E Smith; James B Rottman; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2011-11-25       Impact factor: 10.793

7.  A committed precursor to innate lymphoid cells.

Authors:  Michael G Constantinides; Benjamin D McDonald; Philip A Verhoef; Albert Bendelac
Journal:  Nature       Date:  2014-02-09       Impact factor: 49.962

8.  Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice.

Authors:  Emily Hams; Richard M Locksley; Andrew N J McKenzie; Padraic G Fallon
Journal:  J Immunol       Date:  2013-10-28       Impact factor: 5.422

9.  Nfil3 is required for the development of all innate lymphoid cell subsets.

Authors:  Cyril Seillet; Lucille C Rankin; Joanna R Groom; Lisa A Mielke; Julie Tellier; Michael Chopin; Nicholas D Huntington; Gabrielle T Belz; Sebastian Carotta
Journal:  J Exp Med       Date:  2014-08-04       Impact factor: 14.307

10.  Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses.

Authors:  Timotheus Y F Halim; You Yi Hwang; Seth T Scanlon; Habib Zaghouani; Natalio Garbi; Padraic G Fallon; Andrew N J McKenzie
Journal:  Nat Immunol       Date:  2015-11-02       Impact factor: 25.606

View more
  11 in total

1.  Peripheral Administration of NMU Promotes White Adipose Tissue Beiging and Improves Glucose Tolerance.

Authors:  Yue Yuan; Hongdong Wang; Jielei He; Haixiang Sun; Dalong Zhu; Yan Bi
Journal:  Int J Endocrinol       Date:  2021-08-02       Impact factor: 3.257

2.  CD52-targeted depletion by Alemtuzumab ameliorates allergic airway hyperreactivity and lung inflammation.

Authors:  Pedram Shafiei-Jahani; Doumet Georges Helou; Benjamin P Hurrell; Lauriane Galle-Treger; Emily Howard; Christine Quach; Jacob D Painter; Marshall Fung; Richard Lo; Hooman Allayee; Omid Akbari
Journal:  Mucosal Immunol       Date:  2021-03-17       Impact factor: 7.313

Review 3.  Social Networking of Group Two Innate Lymphoid Cells in Allergy and Asthma.

Authors:  Benjamin P Hurrell; Pedram Shafiei Jahani; Omid Akbari
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

4.  DUSP10 constrains innate IL-33-mediated cytokine production in ST2hi memory-type pathogenic Th2 cells.

Authors:  Takeshi Yamamoto; Yusuke Endo; Atsushi Onodera; Kiyoshi Hirahara; Hikari K Asou; Takahiro Nakajima; Toshio Kanno; Yasuo Ouchi; Satoshi Uematsu; Hiroshi Nishimasu; Osamu Nureki; Damon J Tumes; Naoki Shimojo; Toshinori Nakayama
Journal:  Nat Commun       Date:  2018-10-12       Impact factor: 14.919

Review 5.  Molecules and Prostaglandins Related to Embryo Tolerance.

Authors:  Gabriel Mayoral Andrade; Gabriela Vásquez Martínez; Laura Pérez-Campos Mayoral; María Teresa Hernández-Huerta; Edgar Zenteno; Eduardo Pérez-Campos Mayoral; Margarito Martínez Cruz; Ruth Martínez Cruz; Carlos Alberto Matias-Cervantes; Noemi Meraz Cruz; Carlos Romero Díaz; Eli Cruz-Parada; Eduardo Pérez-Campos
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

6.  CD200-CD200R immune checkpoint engagement regulates ILC2 effector function and ameliorates lung inflammation in asthma.

Authors:  Pedram Shafiei-Jahani; Doumet Georges Helou; Benjamin P Hurrell; Emily Howard; Christine Quach; Jacob D Painter; Lauriane Galle-Treger; Meng Li; Yong-Hwee Eddie Loh; Omid Akbari
Journal:  Nat Commun       Date:  2021-05-05       Impact factor: 14.919

7.  Expression of Caspase-3 in Circulating Innate Lymphoid Cells Subtypes Is Altered by Treatment with Metformin and Fluvastatin in High-Fat Diet Fed C57BL/6 Mice.

Authors:  Vuyolwethu Mxinwa; Bongani B Nkambule; Tawanda M Nyambuya; Phiwayinkosi V Dludla
Journal:  Cells       Date:  2022-04-23       Impact factor: 6.600

8.  LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity.

Authors:  Doumet Georges Helou; Pedram Shafiei-Jahani; Benjamin P Hurrell; Jacob D Painter; Christine Quach; Emily Howard; Omid Akbari
Journal:  J Allergy Clin Immunol       Date:  2021-06-16       Impact factor: 10.793

9.  PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity.

Authors:  Doumet Georges Helou; Pedram Shafiei-Jahani; Richard Lo; Emily Howard; Benjamin P Hurrell; Lauriane Galle-Treger; Jacob D Painter; Gavin Lewis; Pejman Soroosh; Arlene H Sharpe; Omid Akbari
Journal:  Nat Commun       Date:  2020-08-10       Impact factor: 14.919

10.  Distinct Roles of LFA-1 and ICAM-1 on ILC2s Control Lung Infiltration, Effector Functions, and Development of Airway Hyperreactivity.

Authors:  Benjamin P Hurrell; Emily Howard; Lauriane Galle-Treger; Doumet Georges Helou; Pedram Shafiei-Jahani; Jacob D Painter; Omid Akbari
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.